Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis.
Hematopoietic stem cell transplantation for MS: extraordinary evidence still needed.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
Timing of birth and risk of multiple sclerosis: population based study.
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells.
Association Between Sleep Problems and Perceived Cognitive Dysfunction Over 12 Months in Individuals with Multiple Sclerosis.
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
Policy: NIH to balance sex in cell and animal studies.
Dimethyl fumarate induces necroptosis in colon cancer cells through glutathione depletion/ROS increase/MAPKs activation pathway.
The pathogenesis of demyelinating form of Guillain-Barre syndrome: proteo-peptidomic and immunological profiling of physiological fluids.
Dimethyl fumarate protects pancreatic islet cells and non-endocrine tissue in L-arginine-induced chronic pancreatitis.
Switching patients at high risk of PML from natalizumab to another disease-modifying therapy.
Neurons and astroglia govern microglial endotoxin tolerance through macrophage colony-stimulating factor receptor-mediated ERK1/2 signals.
[Prevalence of multiple sclerosis in the Region of Murcia].
New TECFIDERA® (dimethyl fumarate) data show sustained efficacy and long-term safety in a broad range of multiple sclerosis patients
Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
Effects of dimethyl fumarate on lymphocyte subsets.
Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder.
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis.
Teriflunomide
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.
Pages
« first
‹ previous
…
36
37
38
39
40
41
42
43
44
…
next ›
last »